Ischemia modified albumin levels and oxidative stress in patients with bladder cancer

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 5, 2013, Pages 2759-2763

  Ellidag, Hamit Yasar ^a   Eren, Esin ^b   Aydin, Ozgur ^a   Akgol, Evren ^c   Yalcinkaya, Soner ^a   Sezer, Cem ^d   Yilmaz, Necat ^a  

^a Research Hospital of Ministry of Health   (Turkey)

^b Antalya Public Health Center of Ministry of Health   (Turkey)

^c Izmir Ataturk Research and Training Hospital   (Turkey)

^d Research Hospital of Ministry of Health   (Turkey)

Author keywords

Bladder cancer; Ischemia modified albumin; Oxidative stress; Total antioxidant status; Total oxidant status

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; ISCHEMIA-MODIFIED ALBUMIN; OXIDIZING AGENT; SERUM ALBUMIN;

AGED; BLADDER TUMOR; BLOOD; HUMAN; ISCHEMIA; MALE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; QUESTIONNAIRE;

AGED; ANTIOXIDANTS; BIOLOGICAL MARKERS; HUMANS; ISCHEMIA; MALE; OXIDANTS; OXIDATIVE STRESS; QUESTIONNAIRES; SERUM ALBUMIN; URINARY BLADDER NEOPLASMS;

EID: 84880378791     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.5.2759     Document Type: Article

References (33)

1. Badjatia N, Satyam A, Singh P, Seth A, Sharma A (2010). Altered antioxidant status and lipid peroxidation in Indian patients with urothelial bladder carcinoma. Urol Oncol, 28, 360-7.
2. Ballmer PE, Ochsenbein AF, Schutz-Hofmann S (1994). Transcapillary escape rate of albumin positively correlates with plasma albumin concentration in acute but not in chronic inflammatory disease. Metabolism, 43, 697-705.
3. Bar-Or D, Lau E, Winkler JV (2000). A novel assay for cobaltalbumin binding and its potential as a marker for myocardial ischemia-A Preliminary Report. Emerg Med J, 19, 311-5.
4. Can M, Demirtas S, Polat O, Yildiz A (2006). Evaluation of effects of ischaemia on the albumin cobalt binding (ACB) assay in patients exposed to trauma. Emerg Med J, 23, 537.
5. Christenson RH, Duh SH, Sanhai WR (2001). Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients: a multicenter study. Clinical Chemistry, 47, 464-70.
6. Crawford A, Fassett RG, Geraghty DP, et al (2012). Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease. Gene, 501, 89-103.
7. Di Fiore F, Lecleire S, Pop D, et al (2007). Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer. Am J Gastroenterol, 102, 2557-63.
8. Erel O (2004). A novel automated direct measurement method for total antioxidant capacity using a new generationmore stable ABTS radical cation. Clin Biochem, 37, 277-85.
9. Erel O (2005). A new automated colorimetric method for measuring total oxidant status. Clin Biochem, 38, 1103-11.
10. Ferlay J, Shin H, Bray F, Mathers C, Parkin DM (2008). GLOBOCAN, (IARC) Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: IARC Press, 2010.
11. Fidan E, Mentese A, Kavgaci H, et al (2012). Increased ischemiamodified albumin levels in patients with gastric cancer. Neoplasma, 59, 393-7
12. Gecit I, Aslan M, Gunes M, et al (2012) Serum prolidase activity, oxidative stress, and nitric oxide levels in patients with bladder cancer. J Cancer Res Clin Oncol, 138, 739-43.
13. Harma M, Harma M, Erel O (2003). Increased oxidative stress in patients with hydatidiform mole. Swiss MedWkly, 133, 563-66.
14. Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K (2007). Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg, 246, 1047-51.
15. Kotur-Stevuljevic J, Memon L, Stefanovic A, et al (2007). Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients. Clin Biochem, 40, 181-7.
16. Lippi G, Montagnana M (2009). Ischemia-modified albumin in ischemic disorders. Ann Thorac Cardiovasc Surg, 15, 137.
17. Lippi G, Montagnana M, Salvagno GL, Guidi GC (2007). Standardization of ischaemia modified albumin testing: adjustment for serum albumin. Clin Chem Lab Med, 45, 261-2.
18. Mantovani A, Allavena P, Sica A, Balkwill F (2008). Cancerrelated inflammation. Nature, 454, 436-44.
19. Mastella AK, Moresco RN, Bisognin da Silva D, et al (2009). Evaluation of ischemia-modified albumin in myocardial infarction and prostatic diseases. Biomed Pharmacother, 63, 762-6.
20. Montagnana M, Lippi G, Volpe A, et al (2006). Evaluation of cardiac laboratory markers in patients with systemic sclerosis. Clin Biochem, 39, 913-7.
21. Piwowar A, Knapik-Kordecka M, Warwas M (2008). Ischemiamodified albumin level in type 2 diabetes mellitus - Preliminary report. Dis Markers, 24, 311-7.
22. Refaai MA, Wright RW, Parvin CA, et al (2006). Ischemia modified albumin increases after skeletal muscle ischemia during arthroscopic knee surgery. Clin Chim Acta, 366, 264-8.
23. Roy D, Quiles J, Sharma R, et al (2004). Ischemia modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. Clin Chem, 50, 1656-60.
24. Roy D, Quilles J, Gaze DC, et al (2006). Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart, 92, 113-4.
25. Senes M, Kazan N, Coskun O, et al (2007). Oxidative and nitrosative stress in acute ischaemic stroke. Ann Clin Biochem, 44, 43-7.
26. Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC (2004). Role of ''ischemia modified albumin'', a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J, 21, 29-34.
27. Stachowicz-Stencel T, Synakiewicz A, Owczarzak A, Sliwinska A (2011). Ischemia-Modified Albumin as a biochemical marker in children with neuroblastoma and soft tissue sarcomas. Clin Lab Anal, 25, 255-8
28. Van der Zee PM, Verberne HJ, van Straalen JP, et al (2005) Ischemia-modified albumin measurements in symptom limited exercise myocardial perfusion scintigraphy reflect serum albumin concentrations but not myocardial ischemia. Clin Chem, 51, 1744-6.
29. Van Rijn BB, Franx A, Sikkema JM, et al (2008). Ischemia modified albumin in normal pregnancy and preeclampsia. Hypertens Pregnancy, 27, 159-67.
30. Vassalle C, Pratali L, Boni C, Mercuri A, Ndreu R (2008). An oxidative stress score as a combined measure of the pro-oxidant and antioxidant counterparts in patients with coronary artery disease. Clin Biochem, 41, 1162-7.
31. Von Meyenfeldt M (2005). Cancer-associated malnutrition: an introduction. Eur J Oncol Nurs, 9, 35-8.
32. Yeun JY, Kaysen GA (1998). Factors influencing serum albumin in dialysis patients. Am J Kidney Dis, 32, 118-25.
33. Zapico-Muniz E, Santalo-Bel M, Merce-Muntanola J, et al (2004). Ischemia-modified albumin during skeletal muscle ischemia. Clin Chem, 50, 1063-5.